This 2009 hypothesis paper by Daniel J. Cameron critically examines the limitations of existing evidence used to deny antibiotic therapy for chronic Lyme disease (CLD). The author identifies eight key limitations, including inadequate study power, heterogeneity of data, unaddressed risks of long-term illness, and lack of consideration for co-infections and
